CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 173 filers reported holding CLOVIS ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $125,000 | -62.3% | 31,436 | +40.7% | 0.00% | – |
| Q2 2019 | $332,000 | -62.4% | 22,338 | -37.2% | 0.00% | -100.0% |
| Q1 2019 | $883,000 | -40.7% | 35,560 | -29.8% | 0.00% | 0.0% |
| Q3 2018 | $1,488,000 | -83.3% | 50,665 | -74.1% | 0.00% | -88.9% |
| Q2 2018 | $8,886,000 | -16.1% | 195,425 | -2.6% | 0.01% | -10.0% |
| Q1 2018 | $10,594,000 | -35.2% | 200,628 | -16.5% | 0.01% | -23.1% |
| Q4 2017 | $16,340,000 | -23.1% | 240,291 | -6.9% | 0.01% | -27.8% |
| Q3 2017 | $21,258,000 | +61.5% | 257,984 | +81.7% | 0.02% | +38.5% |
| Q2 2017 | $13,162,000 | +465.9% | 141,993 | +288.6% | 0.01% | +550.0% |
| Q1 2017 | $2,326,000 | -34.9% | 36,538 | -80.4% | 0.00% | -50.0% |
| Q1 2016 | $3,573,000 | -39.7% | 186,084 | +9.0% | 0.00% | -42.9% |
| Q4 2015 | $5,924,000 | -60.6% | 170,680 | +4.5% | 0.01% | -61.1% |
| Q3 2015 | $15,018,000 | +72.2% | 163,310 | +64.6% | 0.02% | +100.0% |
| Q2 2015 | $8,719,000 | -40.9% | 99,215 | -50.1% | 0.01% | -47.1% |
| Q1 2015 | $14,765,000 | +32.3% | 198,910 | -0.2% | 0.02% | +41.7% |
| Q4 2014 | $11,157,000 | +563.3% | 199,225 | +437.3% | 0.01% | +500.0% |
| Q3 2014 | $1,682,000 | +13.1% | 37,080 | +3.3% | 0.00% | 0.0% |
| Q2 2014 | $1,487,000 | – | 35,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |